Amedeo Smart

Free Medical Literature Service

 

Amedeo

HIV Infection
  Free Subscription

Articles published in
J Infect Dis
    July 2024
  1. AGRAWAL P, Giron LB, Singh S, Haw NJ, et al
    Pre-pandemic Metabolic Correlates of COVID-19 Severity and Long COVID Incidence in People Living with HIV.
    J Infect Dis. 2024 Jul 16:jiae362. doi: 10.1093.
    >> Share

  2. BLENKINSOP A, Pantazis N, Kostaki EG, Sofocleous L, et al
    Sources of Human Immunodeficiency Virus Infections Among Men Who Have Sex With Men With a Migration Background: A Viral Phylogenetic Case Study in Amsterdam, The Netherlands.
    J Infect Dis. 2024 Jul 8:jiae267. doi: 10.1093.
    >> Share

    June 2024
  3. WANG F, Rademeyer K, Namuju OC, Abdusalaamu K, et al
    Post-mortem analysis of dolutegravir, tenofovir, lamivudine and efavirenz penetration in multiple CNS compartments.
    J Infect Dis. 2024 Jun 20:jiae325. doi: 10.1093.
    >> Share

  4. CHOW EPF, Stevens K, De Petra V, Chen MY, et al
    Prevalence of cefixime-resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021-2022.
    J Infect Dis. 2024 Jun 15:jiae313. doi: 10.1093.
    >> Share

  5. JACOBSON DL, Crider KS, DeMarrais P, Brummel S, et al
    Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants.
    J Infect Dis. 2024 Jun 15:jiae308. doi: 10.1093.
    >> Share

  6. RUSHMORE J, Learner ER, Bernstein KT
    Expanding the Evidence Base for Improving Sexual Health Among Transgender Communities: The Importance of Rigorous Epidemiologic Studies.
    J Infect Dis. 2024;229:1603-1605.
    >> Share

  7. AMSTUTZ A, Chammartin F, Audige A, Eichenberger AL, et al
    Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3).
    J Infect Dis. 2024 Jun 7:jiae291. doi: 10.1093.
    >> Share

    May 2024
  8. KANKAKA EN, Poon AFY, Quinn TC, Chang LW, et al
    Impact of variable sampling on estimates of HIV-1 reservoir formation dates.
    J Infect Dis. 2024 May 31:jiae294. doi: 10.1093.
    >> Share

  9. DURSTENFELD MS, Wilson MP, Jankowski CM, Ditzenberger GL, et al
    Chronotropic Incompetence among People with HIV Improves with Exercise Training in the Exercise for Healthy Aging Study.
    J Infect Dis. 2024 May 28:jiae284. doi: 10.1093.
    >> Share

  10. SPRINGER YP, Tompkins ML, Newell K, Jones M, et al
    Characterizing the etiology of recurrent tuberculosis using whole genome sequencing-Alaska, USA, 2008-2020.
    J Infect Dis. 2024 May 24:jiae275. doi: 10.1093.
    >> Share

  11. ALLEN LI, Fraser H, Stone J, McAuley A, et al
    Testing and Treatment Interventions in Community Settings Key to Controlling a Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Glasgow: A Modeling Study.
    J Infect Dis. 2024 May 22:jiae206. doi: 10.1093.
    >> Share

  12. MCCLUSKEY SM, Muyindike WR, Nanfuka V, Omoding D, et al
    Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective Observational Cohort Study (DISCO): 48-week Results.
    J Infect Dis. 2024 May 16:jiae260. doi: 10.1093.
    >> Share

  13. SMITH CL, Didion E, Aung H, Tamilselvan B, et al
    Longitudinal analysis of nursing home residents' T cell responses after SARS-CoV-2 mRNA vaccinations shows influence of biological sex and SARS-CoV-2 infection history.
    J Infect Dis. 2024 May 14:jiae234. doi: 10.1093.
    >> Share

  14. MASIA M, Garcia JA, Garcia-Abellan J, Padilla S, et al
    Distinct gut microbiota signatures associated with progression of atherosclerosis in people living with HIV.
    J Infect Dis. 2024 May 14:jiae243. doi: 10.1093.
    >> Share

  15. MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al
    Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.
    J Infect Dis. 2024 May 14:jiae241. doi: 10.1093.
    >> Share

  16. SERRANO-VILLAR S, Martinez E
    The Gut Microbiome: Another Piece in the Puzzle of HIV-Associated Atherosclerosis.
    J Infect Dis. 2024 May 14:jiae244. doi: 10.1093.
    >> Share

  17. PATHELA P, Townsend MB, Kopping EJ, Tang J, et al
    Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022.
    J Infect Dis. 2024 May 13:jiae181. doi: 10.1093.
    >> Share

  18. NICHOLSON LK, Kofonow JM, Robertson CE, Wright T, et al
    Clinical and Microbial Determinants of Upper Respiratory Colonization with Streptococcus pneumoniae and Native Microbiota in People with HIV-1 and Control Adults.
    J Infect Dis. 2024 May 8:jiae247. doi: 10.1093.
    >> Share

  19. SINGH OP, Chaubey R, Kushwaha AK, Fay MP, et al
    Visceral Leishmaniasis-Human Immunodeficiency Virus-Coinfected Patients Are Highly Infectious to Sandflies in an Endemic Area in India.
    J Infect Dis. 2024 May 7:jiae156. doi: 10.1093.
    >> Share

  20. WU L, Kinuthia J, Anderson PL, Baeten JM, et al
    Drug concentrations in hair and dried blood spots as PrEP adherence metrics during pregnancy and postpartum.
    J Infect Dis. 2024 May 3:jiae208. doi: 10.1093.
    >> Share

  21. BERKOWITZ SA
    The Benefits of Medically Tailored Meals for People Living with HIV.
    J Infect Dis. 2024 May 2:jiae196. doi: 10.1093.
    >> Share

  22. PALAR K, Sheira LA, Frongillo EA, O'Donnell AA, et al
    Food is Medicine for HIV: Improved health and hospitalizations in the Changing Health through Food Support (CHEFS-HIV) pragmatic randomized trial.
    J Infect Dis. 2024 May 2:jiae195. doi: 10.1093.
    >> Share

    April 2024
  23. GILLIS N, Dickey BL, Colin-Leitzinger C, Tang YH, et al
    Clonal hematopoiesis in patients with HIV and cancer.
    J Infect Dis. 2024 Apr 24:jiae212. doi: 10.1093.
    >> Share

  24. RIDDLER SA, Kelly CW, Hoesley CJ, Ho KS, et al
    A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.
    J Infect Dis. 2024 Apr 24:jiae211. doi: 10.1093.
    >> Share

  25. MURENZI G, Kim HY, Mivumbi JP, Gasana J, et al
    Incidence, Clearance and Persistence of Penile High-Risk Human Papillomavirus among Rwandan Men who have Sex with Men.
    J Infect Dis. 2024 Apr 16:jiae190. doi: 10.1093.
    >> Share

  26. BEGRE L, Boyd A, Plissonnier ML, Testoni B, et al
    Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
    J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093.
    >> Share

  27. VAN TEIJLINGEN NH, van Smoorenburg MY, Sarrami-Forooshani R, Zijlstra-Willems EM, et al
    Prevotella timonensis bacteria associated with vaginal dysbiosis enhance HIV-1 susceptibility of vaginal CD4+ T cells.
    J Infect Dis. 2024 Apr 4:jiae166. doi: 10.1093.
    >> Share

  28. BAR ZIV O, Cahn A, Jansen T, Istomin V, et al
    Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living with HIV- Evaluation of Clinical and Microbiome Parameters.
    J Infect Dis. 2024 Apr 1:jiae167. doi: 10.1093.
    >> Share

  29. BERENGUER J, Jarrin I, Bellon JM, Diez C, et al
    Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients with HIV.
    J Infect Dis. 2024 Apr 1:jiae168. doi: 10.1093.
    >> Share

    March 2024
  30. XIU F, Flores Anato JL, Cox J, Grace D, et al
    Characteristics of the Sexual Networks of Men Who Have Sex With Men in Montreal, Toronto, and Vancouver: Insights from Canada's 2022 Mpox Outbreak.
    J Infect Dis. 2024;229.
    >> Share

  31. SNYDER RE, Saadeh K, Tang EC, Johnson KA, et al
    Sexual Exposures Associated With Mpox Infection: California, November 2022 to June 2023.
    J Infect Dis. 2024;229.
    >> Share

  32. OLSSON O, Sokilde R, Tesfaye F, Karlson S, et al
    Tuberculosis disease is associated with elevated plasma ribonuclease activity in antiretroviral treatment-naive people with HIV.
    J Infect Dis. 2024 Mar 25:jiae143. doi: 10.1093.
    >> Share

  33. ZEEB M, Frischknecht P, Huber M, Schenkel CD, et al
    Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
    J Infect Dis. 2024 Mar 20:jiae149. doi: 10.1093.
    >> Share

  34. GRUNER E, Grossegesse M, Stern D, Ober V, et al
    Mpox-specific immune responses elicited by vaccination or infection in people living with HIV.
    J Infect Dis. 2024 Mar 13:jiae138. doi: 10.1093.
    >> Share

  35. BURDORF R, Zhou S, Amon C, Long N, et al
    Impact Of Low-Frequency HIV-1 Drug Resistance Mutations On Antiretroviral Therapy Outcomes.
    J Infect Dis. 2024 Mar 11:jiae131. doi: 10.1093.
    >> Share

  36. COLON W, Oriol Mathieu V, Hural J, Hattingh L, et al
    HIV Diagnostics and Vaccines: It Takes Two to Tango.
    J Infect Dis. 2024 Mar 7:jiae113. doi: 10.1093.
    >> Share

  37. WILCOX CS, Herbert C, Wang C, Ma Y, et al
    Signals From Inflamed Perivascular Adipose Tissue Contribute to Small Vessel Dysfunction in Women Living With the Human Immunodeficiency Virus.
    J Infect Dis. 2024 Mar 1:jiae094. doi: 10.1093.
    >> Share

    February 2024
  38. XIAO G, Huang W, Zhong Y, Ou M, et al
    Uncovering the Bronchoalveolar Single-Cell Landscape of Patients With Pulmonary Tuberculosis With Human Immunodeficiency Virus Type 1 Coinfection.
    J Infect Dis. 2024 Feb 27:jiae042. doi: 10.1093.
    >> Share

  39. PIHL RMF, Smith-Mahoney EL, Olson A, Yuen RR, et al
    Distinct subsets of Vdelta1 effector and Vdelta2 gammadelta T cells shift in frequency and are linked to plasma inflammatory markers during ART-suppressed HIV infection.
    J Infect Dis. 2024 Feb 23:jiae091. doi: 10.1093.
    >> Share

  40. COLLAZOS J, Asensi V
    Non-invasive liver fibrosis markers in the evaluation of fibrosis regression after direct-acting antiviral (DAA) therapy.
    J Infect Dis. 2024 Feb 23:jiae095. doi: 10.1093.
    >> Share

  41. THIELE RJ, Grunhagel B, Muenchhoff M, Pujantell-Graell M, et al
    Magnitude of Type I Interferon Responses by Plasmacytoid Dendritic Cells After TLR7 Stimulation Is Associated With Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir Sizes in Cisgender Women With HIV-1 on Antiretroviral Therapy.
    J Infect Dis. 2024 Feb 22:jiae013. doi: 10.1093.
    >> Share

  42. SHIAU S, Zumpano F, Wang Z, Shah J, et al
    Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With HIV.
    J Infect Dis. 2024 Feb 15:jiae016. doi: 10.1093.
    >> Share

  43. JOHNSON JA, Li JF, Politch JA, Lipscomb JT, et al
    HIV Immunocapture Reveals Particles Expressed in Semen under INSTI-based Therapy are Largely Myeloid Cell-Derived and Disparate from Circulating Provirus.
    J Infect Dis. 2024 Feb 13:jiae073. doi: 10.1093.
    >> Share

  44. GAY CL, Hanley PJ, Falcinelli SD, Kuruc JD, et al
    The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy.
    J Infect Dis. 2024 Feb 13:jiad423. doi: 10.1093.
    >> Share

  45. MUSONDA T, Wallace MS, Patel H, Martin OP, et al
    New window into hepatitis B in Africa: Liver sampling combined with single cell omics enables deep and longitudinal assessment of intrahepatic immunity in Zambia.
    J Infect Dis. 2024 Feb 9:jiae054. doi: 10.1093.
    >> Share

  46. WANG X, Zhang Y, Xiao J, Song C, et al
    Effect of vaginal microecological disorders on the increased risk of abnormal cervical cytology among women living with HIV in China.
    J Infect Dis. 2024 Feb 5:jiae058. doi: 10.1093.
    >> Share

  47. SWARTZ TH, Apewokin S, Carpenter SM, Chakraborty R, et al
    A Call to Action: Urgently Strengthening the Future Physician-Scientist Workforce in Infectious Diseases.
    J Infect Dis. 2024 Feb 3:jiad610. doi: 10.1093.
    >> Share

    January 2024
  48. RIDOLFI F, Amorim G, Peetluk LS, Haas DW, et al
    Prediction models for adverse drug reactions during tuberculosis treatment in Brazil.
    J Infect Dis. 2024 Jan 23:jiae025. doi: 10.1093.
    >> Share

  49. RITTER JM, Martines RB, Bhatnagar J, Rao AK, et al
    Pathology and monkeypox virus localization in tissues from immunocompromised patients with severe or fatal mpox.
    J Infect Dis. 2024 Jan 18:jiad574. doi: 10.1093.
    >> Share

  50. LIU Z, Julius P, Himwaze CM, Mucheleng'anga LA, et al
    Cannabis Use Associates With Reduced Proviral Burden and Inflammatory Cytokine in Tissues From Men With Clade C HIV-1 on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2024 Jan 18:jiad575. doi: 10.1093.
    >> Share

  51. BROWN EE, Patel EU, Poteat TC, Mayer K, et al
    Prevalence of sexually transmitted infections among transgender women living with and without HIV in the eastern and southern United States.
    J Infect Dis. 2024 Jan 17:jiad605. doi: 10.1093.
    >> Share

  52. ESSER PL, Quintanares GHR, Langhans B, Heger E, et al
    Torque Teno Virus load is associated with CDC stage and CD4+ cell count in people living with HIV but unrelated to AIDS-defining events and Human Pegivirus load.
    J Infect Dis. 2024 Jan 17:jiae014. doi: 10.1093.
    >> Share

  53. ABELA IA, Hauser A, Schwarzmuller M, Pasin C, et al
    Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study.
    J Infect Dis. 2024 Jan 16:jiae002. doi: 10.1093.
    >> Share

  54. SCRIMIERI F, Bastian E, Smith M, Rehm CA, et al
    Transcriptionally-active "defective" HIV-1 proviruses and their association with immunological non-response to antiretroviral therapy.
    J Infect Dis. 2024 Jan 16:jiae009. doi: 10.1093.
    >> Share

  55. MCGETTRICK P, Tinago W, O'Brien J, Miles S, et al
    Distinct Inflammatory Phenotypes are associated with subclinical and clinical Cardiovascular disease in People living with HIV.
    J Infect Dis. 2024 Jan 12:jiae007. doi: 10.1093.
    >> Share

  56. MILLER JS, Rhein J, Davis ZB, Cooley S, et al
    Safety and virologic impact of haploidentical NK cells plus IL-2 or N-803 in HIV infection.
    J Infect Dis. 2024 Jan 11:jiad578. doi: 10.1093.
    >> Share

  57. ALTFELD M, Muller-Trutwin M
    Allogeneic Natural Killer cells - an additional player in HIV cure approaches?
    J Infect Dis. 2024 Jan 11:jiae005. doi: 10.1093.
    >> Share

  58. GIAMMARINO F, de Salazar A, Malet I, Vinuela L, et al
    Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes.
    J Infect Dis. 2024 Jan 11:jiae010. doi: 10.1093.
    >> Share

  59. TROSEID M, Molinaro A, Gelpi M, Vestad B, et al
    Gut Microbiota Alterations and Circulating Imidazole Propionate Levels are Associated with Obstructive Coronary Artery Disease in People Living with HIV.
    J Infect Dis. 2024 Jan 9:jiad604. doi: 10.1093.
    >> Share

  60. HUYNH J, Le NHT, Nguyen BHL, Hoang HT, et al
    The ability of a 3-gene host signature in blood to distinguish tuberculous meningitis from other brain infections.
    J Infect Dis. 2024 Jan 3:jiad606. doi: 10.1093.
    >> Share

    December 2023
  61. CHIKA-IGWENYI NM, Unigwe US, Ajayi NA, Onwe OE, et al
    Atypical Mpox in a Nigerian Tertiary Health Facility.
    J Infect Dis. 2023 Dec 29:jiad607. doi: 10.1093.
    >> Share

  62. MAKAROVA N, Singletary T, Peet MM, Mitchell J, et al
    Extended post-exposure protection against vaginal SHIV infection with tenofovir alafenamide fumarate/elvitegravir inserts in macaques.
    J Infect Dis. 2023 Dec 22:jiad599. doi: 10.1093.
    >> Share

  63. ELLIOT E, Polli JW, Patel P, Garside L, et al
    Efficacy, safety, and pharmacokinetics by BMI category in Phase 3/3b cabotegravir + rilpivirine long-acting trials.
    J Infect Dis. 2023 Dec 22:jiad580. doi: 10.1093.
    >> Share

  64. LUCERO-OBUSAN C, Oda G, Schirmer P, Edson C, et al
    Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration.
    J Infect Dis. 2023 Dec 22:jiad600. doi: 10.1093.
    >> Share

  65. BLAZKOVA J, Whitehead EJ, Schneck R, Shi V, et al
    Immunologic and virologic parameters associated with HIV DNA reservoir size in people living with HIV receiving antiretroviral therapy.
    J Infect Dis. 2023 Dec 21:jiad595. doi: 10.1093.
    >> Share

  66. DIONNE JA, Giacani L, Tamhane A, Workowski K, et al
    Prevalence and Predictors of Oral Treponema pallidum Detection by qPCR in Early Syphilis.
    J Infect Dis. 2023 Dec 21:jiad582. doi: 10.1093.
    >> Share

  67. RAMANI H, Gosselin A, Bunet R, Jenabian MA, et al
    IL-32 Drives the Differentiation of Cardiotropic CD4+ T-Cells Carrying HIV DNA in People Living with HIV.
    J Infect Dis. 2023 Dec 19:jiad576. doi: 10.1093.
    >> Share

  68. STALTER RM, Dong TQ, Hendrix CW, Palanee-Phillips T, et al
    Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women using the Dapivirine Vaginal Ring.
    J Infect Dis. 2023 Dec 14:jiad550. doi: 10.1093.
    >> Share

  69. HUANG Y, Abdelgawad A, Turchinovich A, Queen S, et al
    RNA landscapes of brain and brain-derived extracellular vesicles in simian immunodeficiency virus (SIV) infection and central nervous system pathology.
    J Infect Dis. 2023 Dec 11:jiad563. doi: 10.1093.
    >> Share

  70. SMITH RA, Raugi DN, Nixon RS, Seydi M, et al
    Antiviral Activity of Lenacapavir Against HIV-2 Isolates and Drug-resistant HIV-2 Mutants.
    J Infect Dis. 2023 Dec 7:jiad562. doi: 10.1093.
    >> Share

  71. TRUNFIO M, Tang B, Iudicello JE, Ma Q, et al
    Distinct effects of SSRIs and SNRIs on Soluble Biomarkers in Blood and Cerebrospinal Fluid of people with HIV.
    J Infect Dis. 2023 Dec 6:jiad558. doi: 10.1093.
    >> Share

    November 2023
  72. BENLARBI M, Richard J, Bourassa C, Tolbert WD, et al
    Plasmatic HIV-1 soluble gp120 is associated with correlates of immune dysfunction and inflammation in ART-treated individuals with undetectable viremia.
    J Infect Dis. 2023 Nov 30:jiad503. doi: 10.1093.
    >> Share

  73. TUTTLE DJ, Castanha PMS, Nasser A, Wilkins MS, et al
    SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased viremia and Nef antibodies in men with HIV-1.
    J Infect Dis. 2023 Nov 30:jiad544. doi: 10.1093.
    >> Share

  74. O'SHEA J, Zucker J, Stampfer S, Cash-Goldwasser S, et al
    Prolonged mpox disease in people with advanced HIV: characterization of mpox skin lesions.
    J Infect Dis. 2023 Nov 29:jiad532. doi: 10.1093.
    >> Share

  75. WELD ED, McGowan I, Anton P, Fuchs EJ, et al
    Tenofovir Douche as HIV Pre-Exposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, & Pharmacodynamics (DREAM 01).
    J Infect Dis. 2023 Nov 29:jiad535. doi: 10.1093.
    >> Share

  76. DAMHORST GL, Fujita AW, Fitts E, Szabo B, et al
    Multisite mpox infection and viral dynamics among persons with HIV in metro-Atlanta.
    J Infect Dis. 2023 Nov 29:jiad530. doi: 10.1093.
    >> Share

  77. ALDRED B, Scott JY, Aldredge A, Gromer DJ, et al
    Associations between HIV and Severe Mpox in an Atlanta Cohort.
    J Infect Dis. 2023 Nov 24:jiad505. doi: 10.1093.
    >> Share

  78. GILADA T, Ulrich AK, Wang Y, Lama JR, et al
    Viral load dynamics in plasma and semen when ART is initiated during early HIV-1 infection.
    J Infect Dis. 2023 Nov 24:jiad520. doi: 10.1093.
    >> Share

  79. KARAN A, Shah N, Garrigues JM, Alarcomicronn J, et al
    Surveillance of complicated mpox cases unresponsive to oral tecovirimat in Los Angeles County, 2022.
    J Infect Dis. 2023 Nov 23:jiad517. doi: 10.1093.
    >> Share

  80. ZIVICH PN, Cole SR, Edwards JK, Glidden DV, et al
    HIV prevention among men who have sex with men: tenofovir alafenamide combination preexposure prophylaxis versus placebo.
    J Infect Dis. 2023 Nov 16:jiad507. doi: 10.1093.
    >> Share

  81. HAIDAR G, Hodges JC, Bilderback A, Lukanski A, et al
    Prospective assessment of humoral and cellular immune responses to a 3rd COVID-19 mRNA vaccine dose among immunocompromised individuals.
    J Infect Dis. 2023 Nov 16:jiad511. doi: 10.1093.
    >> Share

  82. COMBES JD, Didelot JM, Radenne S, Zaegel-Faucher O, et al
    Cumulative detection of anal high-grade squamous intraepithelial lesions over two-year follow-up in men who have sex with men living with HIV in France.
    J Infect Dis. 2023 Nov 16:jiad506. doi: 10.1093.
    >> Share

  83. FAHERTY EAG, Holly T, Herrera K, Guidry T, et al
    Prior sexually transmitted infections and HIV in mpox patients, Chicago, Illinois-(June 2022-March 2023.
    J Infect Dis. 2023 Nov 8:jiad491. doi: 10.1093.
    >> Share

  84. PETERS BA, Whalen A, Xue X, Topper EF, et al
    Subclinical atherosclerosis across the menopausal transition in women with and without HIV.
    J Infect Dis. 2023 Nov 8:jiad488. doi: 10.1093.
    >> Share

    October 2023
  85. KUSTERS JMA, Brouwer JGM, van Benthem BHB, Heijne JCM, et al
    Global Type-Specific Genital Human Papillomavirus Prevalence in Men, by Sexual Orientation: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2023;228:1023-1032.
    >> Share

  86. PARK SY, Lindner MS, Brick K, Noll N, et al
    Detection of Mpox Virus Using Microbial Cell-free DNA: the Potential of Pathogen-Agnostic Sequencing for Rapid Identification of Emerging Pathogens.
    J Infect Dis. 2023 Oct 12:jiad452. doi: 10.1093.
    >> Share

  87. HALL CDX, Ryan D, Hayford C, Morgan E, et al
    Syphilis Prevalence, Incidence, and Demographic Differences in a Longitudinal Study of Young Sexual and Gender Minority Adults Assigned Male at Birth.
    J Infect Dis. 2023 Oct 10:jiad256. doi: 10.1093.
    >> Share

  88. NAIDOO KK, Highton AJ, Baiyegunhi OO, Bhengu SP, et al
    Early initiation of antiretroviral therapy preserves the metabolic function of CD4+ T-cells in subtype C HIV-1 infection.
    J Infect Dis. 2023 Oct 6:jiad432. doi: 10.1093.
    >> Share

  89. CHIRENJE ZM, Laher F, Dintwe O, Muyoyeta M, et al
    Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.
    J Infect Dis. 2023 Oct 5:jiad434. doi: 10.1093.
    >> Share

  90. FALADE-NWULIA O, Lesko CR, Fojo AT, Keruly JC, et al
    Hepatitis C treatment in people living with HIV: Potential to eliminate disease and disparity.
    J Infect Dis. 2023 Oct 5:jiad433. doi: 10.1093.
    >> Share

  91. LAU CY, Martinez-Orengo N, Lyndaker A, Flavahan K, et al
    Advances and Challenges in Molecular Imaging of Viral Infections.
    J Infect Dis. 2023;228.
    >> Share

    September 2023
  92. LIEBERMAN NAP, Avendano CC, Bakhash SAKM, Nunley E, et al
    Genomic Epidemiology of Treponema pallidum and Circulation of Strains With Diminished tprK Antigen Variation Capability in Seattle, 2021-2022.
    J Infect Dis. 2023 Sep 28:jiad368. doi: 10.1093.
    >> Share

  93. ESCUDERO JN, Mecha J, Richardson BA, Maleche-Obimbo E, et al
    Impact of HIV and peripartum period on Mycobacterium tuberculosis infection detection.
    J Infect Dis. 2023 Sep 28:jiad416. doi: 10.1093.
    >> Share

  94. ABDELGAWAD N, Wasserman S, Abdelwahab MT, Davis A, et al
    Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis.
    J Infect Dis. 2023 Sep 22:jiad413. doi: 10.1093.
    >> Share

  95. FRICKER GP, Ghany MG, Mera J, Pinsky BA, et al
    Tools Needed to Support Same-day Diagnosis and Treatment of Current Hepatitis C Infection.
    J Infect Dis. 2023 Sep 22:jiad177. doi: 10.1093.
    >> Share

  96. CARTWRIGHT EJ, Patel PR
    Opportunities for enhanced prevention and control of hepatitis C through improved screening and testing efforts.
    J Infect Dis. 2023 Sep 22:jiad199. doi: 10.1093.
    >> Share

  97. SALYARDS M, Nijhawan AE, Kuo J, Knights SM, et al
    Prevalence, Incidence, and Predictors of Kaposi Sarcoma-associated Herpesvirus Infection Among Young Men Who Have Sex with Men in the Southern United States.
    J Infect Dis. 2023 Sep 15:jiad384. doi: 10.1093.
    >> Share

  98. VAN DE WEG CAM, Thomazella MV, Marmorato MP, Correia CA, et al
    Levels of angiopoietin-2 are predictive for mortality in yellow fever virus infected patients.
    J Infect Dis. 2023 Sep 15:jiad389. doi: 10.1093.
    >> Share

  99. CHIEN RN, Lu SN, Hui-Min Wu G, Yang WW, et al
    Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan.
    J Infect Dis. 2023;228.
    >> Share

  100. AARON A, Zhong H, Hiebert L, Zhuo Y, et al
    Hepatitis C Elimination in Moldova Is Feasible and Cost-Saving: A Modeling Study.
    J Infect Dis. 2023;228.
    >> Share

  101. HUANG CF, Chen GJ, Hung CC, Yu ML, et al
    HCV Microelimination for High-risk Special Populations.
    J Infect Dis. 2023;228.
    >> Share

  102. UMUTESI J, Yu ML, Lesi O, Ward JW, et al
    Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa.
    J Infect Dis. 2023;228.
    >> Share

  103. DAVY-MENDEZ T, Napravnik S, Hogan BC, Eron JJ, et al
    Hospital Readmissions among Persons with HIV in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies.
    J Infect Dis. 2023 Sep 12:jiad396. doi: 10.1093.
    >> Share

  104. BADILLO-PAULINA R, Juan Carlos RA, Lucia Del Carmen GF, Sergio SR, et al
    Mpox-related ophthalmic disease: a retrospective observational study in a single center in Mexico.
    J Infect Dis. 2023 Sep 8:jiad372. doi: 10.1093.
    >> Share

  105. ROUX H, Chomont N
    Measuring HIV reservoirs: Do we need to choose between quantity and quality?
    J Infect Dis. 2023 Sep 4:jiad381. doi: 10.1093.
    >> Share

    August 2023
  106. ZHANG Y, Lin CL, Weber KM, Xing J, et al
    Association of gut microbiota with objective sleep measures in women with and without HIV infection: the IDOze study.
    J Infect Dis. 2023 Aug 31:jiad371. doi: 10.1093.
    >> Share

  107. CHEW KW, Moser C, Yeh E, Wohl DA, et al
    Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
    J Infect Dis. 2023;228.
    >> Share

  108. FALCINELLI SD, Cooper-Volkheimer AD, Semenova L, Wu E, et al
    Impact of cannabis use on immune cell populations and the viral reservoir in people with HIV on suppressive antiretroviral therapy.
    J Infect Dis. 2023 Aug 22:jiad364. doi: 10.1093.
    >> Share

  109. WILLIAMS A, Menon S, Crowe M, Agarwal N, et al
    Geographic and population distributions of HIV-1 and HIV-2 circulating subtypes: a systematic literature review and meta-analysis (2010-2021).
    J Infect Dis. 2023 Aug 18:jiad327. doi: 10.1093.
    >> Share

  110. CLARK JL, Oldenburg CE, Passaro RC, Segura ER, et al
    Changes in Inflammatory Cytokine Levels in Rectal Mucosa Associated with Neisseria Gonorrheae and/or Chlamydia trachomatis Infection and Treatment Among Men Who Have Sex with Men in Lima, Peru.
    J Infect Dis. 2023 Aug 16:jiad349. doi: 10.1093.
    >> Share

  111. WU Y, Wang Y, Long H, Liu L, et al
    Prevalence of intimate partner violence and associated factors among people living with HIV: a large-sample cross-sectional study in China.
    J Infect Dis. 2023 Aug 11:jiad328. doi: 10.1093.
    >> Share

  112. ROUPHAEL NG, Branche AR, Diemert DJ, Falsey AR, et al
    Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
    J Infect Dis. 2023 Aug 10:jiad323. doi: 10.1093.
    >> Share

  113. SABOURIN KR, Ogolla S, Samayoa Reyes G, Daud I, et al
    Effects of maternal HIV infection on early Kaposi's sarcoma-associated herpesvirus (KSHV) seroconversion in a Kenyan mother-infant cohort.
    J Infect Dis. 2023 Aug 4:jiad310. doi: 10.1093.
    >> Share

  114. BRAUNSTEIN SL, Wahnich A, Lazar R
    COVID-19 outcomes among people with HIV and COVID-19 in New York City.
    J Infect Dis. 2023 Aug 3:jiad311. doi: 10.1093.
    >> Share

  115. SCEVOLA S, Niubo J, Domingo P, Verdejo G, et al
    Decay of human immunodeficiency virus (HIV) RNA in seminal plasma and rectal fluid in treatment-naive adults starting antiretroviral therapy with dolutegravir plus lamivudine or bictegravir/emtricitabine/tenofovir alafenamide.
    J Infect Dis. 2023 Aug 1:jiad304. doi: 10.1093.
    >> Share

    July 2023
  116. JORIMANN L, Tschumi J, Zeeb M, Leemann C, et al
    Absence of proviral HIV-1 evolution in early treated individuals with HIV switching to dolutegravir monotherapy during 48 weeks.
    J Infect Dis. 2023 Jul 27:jiad292. doi: 10.1093.
    >> Share

  117. HU Z, Cordwell T, Nguyen H, Li J, et al
    Effect of the L74I Polymorphism on Fitness of Cabotegravir-Resistant Variants of HIV-1 Subtype A6.
    J Infect Dis. 2023 Jul 27:jiad291. doi: 10.1093.
    >> Share

  118. FIERER DS, Schinkel J
    Redefining the Paradigm: The Role of Sexual Networks and Sexualized Drug Use in the Transmission of HCV Among Men Who Have Sex with Men.
    J Infect Dis. 2023 Jul 24:jiad265. doi: 10.1093.
    >> Share

  119. FRENCH MA
    The Immunopathogenesis of Immune Reconstitution Inflammatory Syndrome Has Become Clearer, but More Complex.
    J Infect Dis. 2023;228:106-110.
    >> Share

  120. PINANA JL, Tridello G, Xhaard A, Wendel L, et al
    Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation.
    J Infect Dis. 2023 Jul 13:jiad268. doi: 10.1093.
    >> Share

  121. ZALLA LC, Cole SR, Eron JJ, Adimora AA, et al
    Evaluating Clinic-Based Interventions to Reduce Racial Differences in Mortality among People with HIV in the United States.
    J Infect Dis. 2023 Jul 12:jiad263. doi: 10.1093.
    >> Share

  122. BERNAL S, Puertas MC, Moron-Lopez S, Cranston RD, et al
    Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.
    J Infect Dis. 2023 Jul 3:jiad251. doi: 10.1093.
    >> Share

    June 2023
  123. MAENETJE P, Baik Y, Schramm DB, Vangu MDW, et al
    Circulating biomarkers, FeNO, and lung function in patients with HIV and tuberculosis.
    J Infect Dis. 2023 Jun 30:jiad232. doi: 10.1093.
    >> Share

  124. TRAUT CC, Jones JL, Sanders RA, Clark LR, et al
    Orthopoxvirus-Specific T Cell Responses in Convalescent MPOX Patients.
    J Infect Dis. 2023 Jun 29:jiad245. doi: 10.1093.
    >> Share

  125. BENNER SE, Zhu X, Hussain S, Florman S, et al
    HIV-positive liver transplant does not alter the latent viral reservoir in recipients with ART-suppressed HIV.
    J Infect Dis. 2023 Jun 28:jiad241. doi: 10.1093.
    >> Share

  126. THUDIUM RF, Arentoft NS, Hoel H, Afzal S, et al
    Elevated levels of Interleukin-1beta and IL-10 are associated with faster lung function decline in well-treated people with HIV.
    J Infect Dis. 2023 Jun 27:jiad233. doi: 10.1093.
    >> Share

  127. ARTENIE A, Stone J, Facente SN, Fraser H, et al
    Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis.
    J Infect Dis. 2023 Jun 24:jiad169. doi: 10.1093.
    >> Share

  128. BURDO TH, Robinson JA, Cooley S, Smith MD, et al
    Increased peripheral inflammation is associated with structural brain changes and reduced blood flow in virologically controlled people with HIV.
    J Infect Dis. 2023 Jun 23:jiad229. doi: 10.1093.
    >> Share

  129. DEYOE JE, Kelly JD, Grijalva CG, Bonenfant G, et al
    Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022.
    J Infect Dis. 2023;227:1343-1347.
    >> Share

  130. ZHOU S, Long N, Moeser M, Hill CS, et al
    Use of Next Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-CoV-2 Pandemic on HIV-1 Diagnosis and Transmission.
    J Infect Dis. 2023 Jun 7:jiad211. doi: 10.1093.
    >> Share

  131. BROWN JA, Hauser A, Abela IA, Pasin C, et al
    Seroprofiling of antibodies against endemic human coronaviruses and SARS-CoV-2 in an HIV cohort in Lesotho: correlates of antibody response and seropositivity.
    J Infect Dis. 2023 Jun 1:jiad197. doi: 10.1093.
    >> Share

    May 2023
  132. WEI F, Alberts CJ, Albuquerque A, Clifford GM, et al
    Impact of human papillomavirus vaccine against anal human papillomavirus infection, anal intraepithelial neoplasia, and recurrence of anal intraepithelial neoplasia: a systematic review and meta-analysis.
    J Infect Dis. 2023 May 31:jiad183. doi: 10.1093.
    >> Share

  133. THIPPABHOTLA S, Adeyemo B, Cooley SA, Roman J, et al
    Comparison of Resting State Functional Connectivity in Persons With and Without HIV: A Cross-sectional Study.
    J Infect Dis. 2023 May 25:jiad180. doi: 10.1093.
    >> Share

  134. SCHWENKE JM, Thorball CW, Schoepf IC, Ryom L, et al
    Association of a Polygenic Risk Score with Osteoporosis in People Living with HIV: The Swiss HIV Cohort Study.
    J Infect Dis. 2023 May 24:jiad179. doi: 10.1093.
    >> Share

  135. SCHALKWIJK HH, Georgala A, Gillemot S, Temblador A, et al
    A Herpes Simplex virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in an Immunocompromised Patient - Confirmed by Gene Editing.
    J Infect Dis. 2023 May 24:jiad184. doi: 10.1093.
    >> Share

  136. SABO MC, Lokken EM, Srinivasan S, Kinuthia J, et al
    Changes in vaginal bacteria and inflammatory mediators from periconception through early-postpartum in a cohort of HIV-negative Kenyan women.
    J Infect Dis. 2023 May 19:jiad168. doi: 10.1093.
    >> Share

  137. HARTANA CA, Garcia Broncano P, Maswabi K, Ajibola G, et al
    Immune modulation of HIV-1 reservoir size in early-treated neonates.
    J Infect Dis. 2023 May 18:jiad173. doi: 10.1093.
    >> Share

  138. DURSTENFELD MS, Peluso MJ, Kaveti P, Hill C, et al
    Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.
    J Infect Dis. 2023 May 11:jiad131. doi: 10.1093.
    >> Share

  139. ROBINSON JA, Mahmud FJ, Greif E, Toribio M, et al
    Osteopontin is an integral mediator of cardiac interstitial fibrosis in models of HIV infection.
    J Infect Dis. 2023 May 10:jiad149. doi: 10.1093.
    >> Share

  140. THIO CL, Taddese M, Saad Y, Zambo K, et al
    HBeAg-negative single hepatocyte analysis shows transcriptional silencing and slow decay of infected cells with treatment.
    J Infect Dis. 2023 May 2:jiad124. doi: 10.1093.
    >> Share

    April 2023
  141. WHITTLES LK, Galiwango RM, Mpagazi J, Tobian AAR, et al
    Age patterns of HSV-2 incidence and prevalence in two Ugandan communities: a catalytic incidence model applied to population-based seroprevalence data.
    J Infect Dis. 2023 Apr 20:jiad113. doi: 10.1093.
    >> Share

  142. ROBINSON JA, Niu M, Fox HS, Burdo TH, et al
    Antiretroviral therapy ameliorates SIV-associated myocarditis by dampening interferon signaling and pathogen response in the heart.
    J Infect Dis. 2023 Apr 19:jiad105. doi: 10.1093.
    >> Share

  143. CLIFFORD GM, Wei F
    Prevention of Human Papillomavirus-Related Anal Cancer in Women Living With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:929-931.
    >> Share

  144. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    >> Share

  145. ALEMNJI G, Mosha F, Maggiore P, Alexander H, et al
    Building Integrated Testing Programs for Infectious Diseases.
    J Infect Dis. 2023 Apr 12:jiad103. doi: 10.1093.
    >> Share

  146. ROCCO JM, Laidlaw E, Galindo F, Anderson M, et al
    Mycobacterial Immune Reconstitution Inflammatory Syndrome in HIV is Associated With Protein-Altering Variants in Hemophagocytic Lymphohistiocytosis-Related Genes.
    J Infect Dis. 2023 Apr 11:jiad059. doi: 10.1093.
    >> Share

  147. RAI MA, Shi V, Kennedy BD, Justement JS, et al
    Impact of mpox virus infection on immune parameters of a female person with HIV receiving clinically effective antiretroviral therapy.
    J Infect Dis. 2023 Apr 6:jiad096. doi: 10.1093.
    >> Share

  148. SUTHAR AB, Ouk V, Samreth S, Ngauv B, et al
    Programmatic Implications of National Recent HIV Infection Surveillance in Cambodia.
    J Infect Dis. 2023 Apr 1:jiad082. doi: 10.1093.
    >> Share

    March 2023
  149. SONG S, Satta S, Sharma MB, Hugo C, et al
    Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection.
    J Infect Dis. 2023 Mar 24:jiad044. doi: 10.1093.
    >> Share

  150. SMITH CL, Bednarchik B, Aung H, Wilk DJ, et al
    Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent Influenza Vaccine in Older Nursing Home Residents.
    J Infect Dis. 2023 Mar 23:jiad071. doi: 10.1093.
    >> Share

  151. JOSEPH SB, Gianella S, Burdo TH, Cinque P, et al
    Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.
    J Infect Dis. 2023;227.
    >> Share

  152. AUNG HL, Alagaratnam J, Chan P, Chow FC, et al
    Cognitive Health in Persons With Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging.
    J Infect Dis. 2023;227.
    >> Share

  153. MUKERJI SS, Petersen KJ, Pohl KM, Dastgheyb RM, et al
    Machine Learning Approaches to Understand Cognitive Phenotypes in People With HIV.
    J Infect Dis. 2023;227.
    >> Share

  154. O'CONNOR EE, Sullivan EV, Chang L, Hammoud DA, et al
    Imaging of Brain Structural and Functional Effects in People With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227.
    >> Share

  155. MCINTOSH RC, Clark US, Cherner M, Cysique LA, et al
    The Evolution of Assessing Central Nervous System Complications in Human Immunodeficiency Virus: Where Do We Go From Here?
    J Infect Dis. 2023;227.
    >> Share

  156. RAO VR, Brouwers P, Joseph J, Lawhorn C, et al
    Biotypes of Central Nervous System Complications in People Living With Human Immunodeficiency Virus (HIV): National Institute of Mental Health Perspectives on Advancing the Future of HIV Healthcare.
    J Infect Dis. 2023;227.
    >> Share

  157. RUBIN LH, Ances BM
    Moving Toward Disentangling Heterogeneity in Central Nervous System Complications in People With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227.
    >> Share

  158. ALKHATIB B, Jabari M, Bilasy S, Abdul-Rahman H, et al
    Resistance to HIV-1 Infection Conferred by a Compound CCR5Delta32 and CCR5 C20S Heterozygote.
    J Infect Dis. 2023 Mar 13:jiad062. doi: 10.1093.
    >> Share

  159. HASTIE E, Moser C, Sun X, Lennox J, et al
    Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy.
    J Infect Dis. 2023 Mar 7:jiad060. doi: 10.1093.
    >> Share

    February 2023
  160. LI Y, You S, Lee K, Yaesoubi R, et al
    The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018.
    J Infect Dis. 2023 Feb 18:jiad047. doi: 10.1093.
    >> Share

  161. POVEDA E, Fitzgerald W, Reglero C, Perez-Gonzalez A, et al
    IL-18 and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1.
    J Infect Dis. 2023 Feb 15:jiad042. doi: 10.1093.
    >> Share

  162. GANDHI RT, Bosch RJ, Mar H, Laird GM, et al
    Varied Patterns of Decay of Intact HIV-1 Proviruses Over two Decades of Art.
    J Infect Dis. 2023 Feb 10:jiad039. doi: 10.1093.
    >> Share

  163. LI P, Li J, Ayada I, Avan A, et al
    Clinical features, antiviral treatment and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks.
    J Infect Dis. 2023 Feb 3:jiad034. doi: 10.1093.
    >> Share

    January 2023
  164. CHAMBERS C, Deeks SL, Sutradhar R, Cox J, et al
    Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men.
    J Infect Dis. 2023 Jan 19:jiad005. doi: 10.1093.
    >> Share

  165. LI Y, Lefebvre F, Nakku-Joloba E, Ronald A, et al
    Upregulation of PTPRC and Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection.
    J Infect Dis. 2023 Jan 13:jiac498. doi: 10.1093.
    >> Share

  166. SHIAU S, Jacobson DL, Huo Y, Kacanek D, et al
    Unique profile of inflammation and immune activation in pregnant people with HIV in the United States.
    J Infect Dis. 2023 Jan 2:jiac501. doi: 10.1093.
    >> Share

  167. PHILLIPS S, Cornall AM, Molano M, Jin F, et al
    Performance of human papillomavirus (HPV) attribution algorithms to predict causative genotypes in anal high-grade lesions.
    J Infect Dis. 2023 Jan 2:jiac503. doi: 10.1093.
    >> Share

    December 2022
  168. REILLY CS, Borges AH, Baker JV, Safo SE, et al
    Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons with HIV.
    J Infect Dis. 2022 Dec 29:jiac496. doi: 10.1093.
    >> Share

  169. DONNELLAN S, Pennington SH, Ruggiero A, Martinez-Rodriguez C, et al
    A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection.
    J Infect Dis. 2022 Dec 20:jiac491. doi: 10.1093.
    >> Share

  170. TOVINH M, Horr G, Hoffmeister C, Dobrikova K, et al
    HIV-associated microbial translocation may affect cytokine production of CD56bright NK cells via stimulation of monocytes.
    J Infect Dis. 2022 Dec 15:jiac485. doi: 10.1093.
    >> Share

  171. DI DIEGO GARCIA F, Cabrerizo G, Paletta A, Perez PS, et al
    Resistance to Prostaglandin E2 promotes monocyte activation during chronic HIV infection.
    J Infect Dis. 2022 Dec 9:jiac480. doi: 10.1093.
    >> Share

  172. HYLE EP, Kasaie P, Schwamm E, Stewart C, et al
    A growing number of men who have sex with men aging with HIV (2021-2031): a comparison of two microsimulation models.
    J Infect Dis. 2022 Dec 7:jiac473. doi: 10.1093.
    >> Share

  173. FOURMAN LT, Stanley TL, Ockene MW, McClure CM, et al
    Proteomic Analysis of Hepatic Fibrosis in HIV-Associated NAFLD Demonstrates Upregulation of Immune Response and Tissue Repair Pathways.
    J Infect Dis. 2022 Dec 3:jiac475. doi: 10.1093.
    >> Share

    November 2022
  174. LABARILE M, Loosli T, Zeeb M, Kusejko K, et al
    Quantifying and predicting ongoing Human Immunodeficiency Virus Type 1 (HIV-1) transmission dynamics in Switzerland using a distance-based clustering approach.
    J Infect Dis. 2022 Nov 26:jiac457. doi: 10.1093.
    >> Share

  175. HAMUSONDE K, Nicca D, Gunthard HF, Stockle M, et al
    Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared.
    J Infect Dis. 2022 Nov 21:jiac459. doi: 10.1093.
    >> Share

  176. JONGKEES MJ, Geers D, Hensley KS, Huisman W, et al
    Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination.
    J Infect Dis. 2022 Nov 19:jiac451. doi: 10.1093.
    >> Share

  177. HAKRE S, Lakhal-Naouar I, King DB, Burns JL, et al
    Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019.
    J Infect Dis. 2022;226:1743-1752.
    >> Share

  178. STIEH DJ, Barouch DH, Comeaux C, Sarnecki M, et al
    Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study.
    J Infect Dis. 2022 Nov 9. pii: 6812747. doi: 10.1093.
    >> Share

  179. PALUMBO PJ, Grant-McAuley W, Grabowski MK, Zhang Y, et al
    Multiple infection and HIV superinfection among persons who inject drugs in Indonesia and Ukraine.
    J Infect Dis. 2022 Nov 8. pii: 6811512. doi: 10.1093.
    >> Share

    October 2022
  180. LI Z, Winer RL, Ba S, Sy MP, et al
    Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance among Women in Senegal, West Africa.
    J Infect Dis. 2022 Oct 31. pii: 6782258. doi: 10.1093.
    >> Share

  181. STRAIN JF, Cooley SA, Tomov D, Boerwinkle A, et al
    Abnormal MRI signature in virologically stable HIV individuals.
    J Infect Dis. 2022 Oct 25. pii: 6770683. doi: 10.1093.
    >> Share

  182. JAO J, Sun S, Bonner LB, Legbedze J, et al
    Lower insulin sensitivity in newborns with in utero HIV and antiretroviral exposure who are uninfected in Botswana.
    J Infect Dis. 2022 Oct 14. pii: 6761332. doi: 10.1093.
    >> Share

  183. ESHLEMAN SH, Fogel JM, Halvas EK, Piwowar-Manning E, et al
    HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention.
    J Infect Dis. 2022 Oct 14. pii: 6761331. doi: 10.1093.
    >> Share

  184. BENET S, Blanch-Lombarte O, Ainsua-Enrich E, Pedreno-Lopez N, et al
    Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PLWH with poor immune reconstitution.
    J Infect Dis. 2022 Oct 6. pii: 6749018. doi: 10.1093.
    >> Share

    September 2022
  185. URIU K, Cardenas P, Munoz E, Barragan V, et al
    Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection.
    J Infect Dis. 2022;226:1200-1203.
    >> Share

  186. SMITH MSR, Mohan H, Ajaykumar A, Hsieh AYY, et al
    Second-generation HIV integrase inhibitors induce differentiation dysregulation and exert toxic effects in human embryonic stem cell and mouse models.
    J Infect Dis. 2022 Sep 19. pii: 6704757. doi: 10.1093.
    >> Share

  187. HALL SA, Burns GS, Mooney BJ, Millen R, et al
    Hepatitis B Virus Flares following Nucleot(s)ide Analogue Cessation Are Associated with Activation of TLR Signalling Pathways.
    J Infect Dis. 2022 Sep 15. pii: 6701634. doi: 10.1093.
    >> Share

  188. PELUSO MJ, Mitchell A, Wang CY, Takahashi S, et al
    Low Prevalence of Interferon-alpha Autoantibodies in People Experiencing Long COVID Symptoms.
    J Infect Dis. 2022 Sep 12. pii: 6696027. doi: 10.1093.
    >> Share

  189. MARGOT NA, Naik V, VanderVeen L, Anoshchenko O, et al
    Resistance analyses in Highly Treatment-Experienced People with HIV Treated with the Novel Capsid HIV Inhibitor Lenacapavir.
    J Infect Dis. 2022 Sep 9. pii: 6694734. doi: 10.1093.
    >> Share

  190. MEHTA SD, Nandi D, Agingu W, Green SJ, et al
    Vaginal and Penile Microbiome Associations With Herpes Simplex Virus Type 2 in Women and Their Male Sex Partners.
    J Infect Dis. 2022;226:644-654.
    >> Share

  191. GAYEDYU-DENNIS D, Fallah MP, Drew C, Badio M, et al
    Identifying pauci-/asymptomatic and unrecognized Ebola virus disease among close contacts based on exposure risk assessments and screening algorithms.
    J Infect Dis. 2022 Sep 1. pii: 6679723. doi: 10.1093.
    >> Share

    August 2022
  192. VETTER BN, Reipold EI, Ongarello S, Audu R, et al
    Sensitivity and Specificity of Rapid Diagnostic Tests for Hepatitis C Virus With or Without HIV Coinfection: A Multicentre Laboratory Evaluation Study.
    J Infect Dis. 2022;226:420-430.
    >> Share

  193. HWA SH, Snyman J, Bernstein M, Ganga Y, et al
    HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization.
    J Infect Dis. 2022 Aug 17. pii: 6670446. doi: 10.1093.
    >> Share

  194. GARDNER AR, Ma Y, Bacchetti P, Price JC, et al
    Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
    J Infect Dis. 2022 Aug 11. pii: 6650396. doi: 10.1093.
    >> Share

  195. SAMSUNDER N, de Vos M, Ngcapu S, Giandhari J, et al
    Clinical evaluation of SARS-CoV-2 rapid antigen tests during the Omicron wave in South Africa.
    J Infect Dis. 2022 Aug 3. pii: 6654839. doi: 10.1093.
    >> Share

    July 2022
  196. VIVALDI G, Jolliffe DA, Faustini S, Shields AM, et al
    Correlation between post-vaccination anti-Spike antibody titres and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study.
    J Infect Dis. 2022 Jul 30. pii: 6652292. doi: 10.1093.
    >> Share

  197. BABALOLA CM, Siebert JC, Kallapur SG, Maecker HT, et al
    Discrete Plasma Cytokine Profiles among Pregnant Women in Botswana by Chlamydia trachomatis infection, HIV status, and Gestational age.
    J Infect Dis. 2022 Jul 25. pii: 6649668. doi: 10.1093.
    >> Share

  198. TORIBIO M, Wilks MQ, Hedgire S, Lu MT, et al
    Increased Macrophage-Specific Arterial Infiltration Relates to Non-calcified Plaque and Systemic Immune Activation in People with HIV.
    J Infect Dis. 2022 Jul 20. pii: 6646962. doi: 10.1093.
    >> Share

  199. MAHANT A, Guerguis S, Blevins TP, Cheshenko N, et al
    Herpes Simplex Virus Glycoprotein D Antibodies Fail to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines.
    J Infect Dis. 2022 Jul 14. pii: 6644507. doi: 10.1093.
    >> Share

  200. ROGANDO AC, Weber KM, Xing J, Xue X, et al
    The IDOze Study: The Link between Sleep Disruption and Tryptophan-Kynurenine Pathway Activation in Women with HIV.
    J Infect Dis. 2022 Jul 8. pii: 6633821. doi: 10.1093.
    >> Share

  201. COSSU MV, Mileto D, Giacomelli A, Oreni L, et al
    Does the co-morbidity burden contribute to suboptimal immunological responses to COVID-19 vaccination in people living with HIV?
    J Infect Dis. 2022 Jul 7. pii: 6633353. doi: 10.1093.
    >> Share

    June 2022
  202. HUNIDZARIRA P, Brown ER, Chirenje ZM, Hillier SL, et al
    Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials.
    J Infect Dis. 2022 Jun 28. pii: 6619245. doi: 10.1093.
    >> Share

  203. LLIBRE JM, Revollo B, Aguilar S, Calomarde-Gomez C, et al
    Protection against severe clinical outcomes with adenovirus or mRNA SARS-CoV-2 vaccines in patients hospitalized with Covid-19.
    J Infect Dis. 2022 Jun 28. pii: 6619237. doi: 10.1093.
    >> Share

  204. HICKEY MD, Imbert E, Appa A, Del Rosario JB, et al
    HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness.
    J Infect Dis. 2022 Jun 27. pii: 6618638. doi: 10.1093.
    >> Share

  205. MOODIE Z, Dintwe O, Sawant S, Grove D, et al
    Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.
    J Infect Dis. 2022 Jun 27. pii: 6618597. doi: 10.1093.
    >> Share

  206. NYAWANDA BO, Otieno NA, Otieno MO, Emukule GO, et al
    The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya.
    J Infect Dis. 2022;225:2097-2105.
    >> Share

  207. CUSTER B, Grebe E, Buccheri R, Bakkour S, et al
    Surveillance for Zika, chikungunya and dengue virus incidence and RNAemia in blood donors at four Brazilian blood centers during 2016-2019.
    J Infect Dis. 2022 Jun 11. pii: 6605709. doi: 10.1093.
    >> Share

  208. QUINN MK, Williams PL, Muhihi A, Duggan CP, et al
    Timing of antiretroviral therapy initiation and birth outcomes among pregnant women living with HIV in Tanzania.
    J Infect Dis. 2022 Jun 9. pii: 6604810. doi: 10.1093.
    >> Share

  209. JACOBSON JM
    Immune Responses to SARS-CoV-2 Vaccination in People With HIV: A Tale of Two Pandemics.
    J Infect Dis. 2022 Jun 7. pii: 6603522. doi: 10.1093.
    >> Share

  210. LAPOINTE HR, Mwimanzi F, Cheung PK, Sang Y, et al
    People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.
    J Infect Dis. 2022 Jun 7. pii: 6603521. doi: 10.1093.
    >> Share

  211. TAYLOR SA, Sharma S, Remmel CAL, Holder B, et al
    HIV-associated alterations of the biophysical features of maternal antibodies correlate with their reduced transfer across the placenta.
    J Infect Dis. 2022 Jun 6. pii: 6603519. doi: 10.1093.
    >> Share

    May 2022
  212. MWIMANZI F, Lapointe HR, Cheung PK, Sang Y, et al
    Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose.
    J Infect Dis. 2022 May 11. pii: 6583561. doi: 10.1093.
    >> Share

  213. KOLOSSVARY M, deFilippi C, Lu MT, Zanni MV, et al
    Proteomic Signature of Subclinical Coronary Artery Disease in People with HIV: Analysis of the REPRIEVE Mechanistic Substudy.
    J Infect Dis. 2022 May 10. pii: 6583088. doi: 10.1093.
    >> Share

  214. EL SAHLY HM, Baden LR, Essink B, Montefiori D, et al
    Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 COVE Trial.
    J Infect Dis. 2022 May 10. pii: 6583011. doi: 10.1093.
    >> Share

  215. CINDI Z, Kawuma AN, Maartens G, Bradford Y, et al
    Pharmacogenetics of dolutegravir plasma exposure among Southern Africans living with HIV.
    J Infect Dis. 2022 May 4. pii: 6580078. doi: 10.1093.
    >> Share

  216. MOHAREB AM, Liu AF, Kim AY, Coffie PA, et al
    Clearance of hepatitis B "e" antigen in untreated chronic HBV infection: a systematic review and meta-analysis.
    J Infect Dis. 2022 May 2. pii: 6576758. doi: 10.1093.
    >> Share

  217. GIBBS A, Healy K, Kaldhusdal V, Sundling C, et al
    MAIT cells are preserved in the cervical mucosa of HIV-infected women and exhibit a dominant expression of the TRAV1-2-TRAJ20 TCRalpha chain.
    J Infect Dis. 2022 May 2. pii: 6576501. doi: 10.1093.
    >> Share

  218. JACOBS JL, Naqvi A, Shah FA, Boltz VF, et al
    Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19.
    J Infect Dis. 2022 May 2. pii: 6576503. doi: 10.1093.
    >> Share

  219. WALKER NF, Karim F, Moosa M, Moodley S, et al
    Elevated Plasma Matrix Metalloproteinase-8 associates with Sputum Culture Positivity in Pulmonary Tuberculosis.
    J Infect Dis. 2022 May 1. pii: 6576469. doi: 10.1093.
    >> Share

    April 2022
  220. CHAUDRON SE, Leemann C, Kusejko K, Nguyen H, et al
    A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV Cohort Study.
    J Infect Dis. 2022 Apr 29. pii: 6575836. doi: 10.1093.
    >> Share

  221. PETERSEN KJ, Strain J, Cooley S, Vaida F, et al
    Machine learning quantifies accelerated white-matter aging in persons with HIV.
    J Infect Dis. 2022 Apr 28. pii: 6575226. doi: 10.1093.
    >> Share

  222. SPATOLA M, Loos C, Cizmeci D, Webb N, et al
    Functional compartmentalization of antibodies in the central nervous system during chronic HIV infection.
    J Infect Dis. 2022 Apr 13. pii: 6568136. doi: 10.1093.
    >> Share

  223. MUGO C, Nduati R, Osoro E, Nyawanda BO, et al
    Comparable pregnancy outcomes for HIV-uninfected and HIV-infected women on antiretroviral treatment in Kenya.
    J Infect Dis. 2022 Apr 11. pii: 6566248. doi: 10.1093.
    >> Share

  224. AFRAN L, Jambo KC, Nedi W, Miles DJC, et al
    Defective monocyte enzymatic function and an inhibitory immune phenotype in HIV-exposed uninfected African infants in the era of antiretroviral therapy.
    J Infect Dis. 2022 Apr 11. pii: 6566242. doi: 10.1093.
    >> Share

  225. LOUVANTO K, Baral P, Burchell A, Ramanakumar A, et al
    Role of Human Leukocyte Antigen Allele Sharing in Human Papillomavirus Infection Transmission Among Heterosexual Couples: Findings From the Hitch Cohort Study.
    J Infect Dis. 2022 Apr 1. pii: 6562380. doi: 10.1093.
    >> Share

  226. EDFELDT G, Lajoie J, Rohl M, Oyugi J, et al
    Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix.
    J Infect Dis. 2022;225:1151-1161.
    >> Share

    March 2022
  227. REEVES RM, van Wijhe M, Lehtonen T, Stona L, et al
    A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis.
    J Infect Dis. 2022 Mar 25. pii: 6554001. doi: 10.1093.
    >> Share

  228. WEI F, Xia N, Ocampo R, Goodman MT, et al
    Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies.
    J Infect Dis. 2022 Mar 23. pii: 6553063. doi: 10.1093.
    >> Share

  229. TOVINH M, Horr G, Dobrikova K, Gotter C, et al
    Mitochondrial dysfunction contributes to impaired cytokine production of CD56 bright NK cells from HIV(+) individuals under effective antiviral therapy.
    J Infect Dis. 2022 Mar 21. pii: 6551690. doi: 10.1093.
    >> Share

  230. ESHLEMAN SH, Fogel JM, Piwowar-Manning E, Chau G, et al
    Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
    J Infect Dis. 2022 Mar 18. pii: 6549543. doi: 10.1093.
    >> Share

  231. RINDLER AE, Kusejko K, Kuster H, Neumann K, et al
    The interplay between replication capacity of HIV-1 and surrogate markers of disease.
    J Infect Dis. 2022 Mar 17. pii: 6550309. doi: 10.1093.
    >> Share

  232. POVEDA E, Tabernilla A, Fitzgerald W, Salgado-Barreira A, et al
    Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control.
    J Infect Dis. 2022;225:1040-1049.
    >> Share

  233. KROON E, Chottanapund S, Buranapraditkun S, Sacdalan C, et al
    Paradoxically greater persistence of HIV RNA+ cells in lymphoid tissue when ART is initiated in the earliest stage of infection.
    J Infect Dis. 2022 Mar 11. pii: 6547240. doi: 10.1093.
    >> Share

  234. TANKO RF, Bunjun R, Dabee S, Jaumdally SZ, et al
    The Effect Of Contraception On Genital Cytokines In Women Randomized To Copper Intrauterine Device, Intramuscular Depot Medroxyprogesterone Acetate Or Levonorgestrel Implant.
    J Infect Dis. 2022 Mar 9. pii: 6545868. doi: 10.1093.
    >> Share

  235. HALL EW, Weng MK, Harris AM, Schillie S, et al
    Assessing the cost-utility of universal hepatitis B vaccination among adults.
    J Infect Dis. 2022 Mar 9. pii: 6545195. doi: 10.1093.
    >> Share

  236. VAN KAMPEN JJA, Dalm VASH, Fraaij PLA, Oude Munnink BB, et al
    Clinical and in-vitro evidence favoring immunoglobulin treatment of a chronic norovirus infection in a patient with common variable immunodeficiency.
    J Infect Dis. 2022 Mar 7. pii: 6543890. doi: 10.1093.
    >> Share

    February 2022
  237. BOTTANELLI M, Ceccarelli D, Galli L, Castagna A, et al
    Response to Cyktor Et Al.
    J Infect Dis. 2022 Feb 26. pii: 6537607. doi: 10.1093.
    >> Share

  238. TEPEKULE B, Kusejko K, Zeeb M, Tarr PE, et al
    Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study.
    J Infect Dis. 2022 Feb 16. pii: 6529706. doi: 10.1093.
    >> Share

  239. PAVLINAC P, Singa B, Huang ML, Shrestha L, et al
    Cytomegalovirus viremia predicts post-discharge mortality in Kenyan HIV-exposed uninfected children.
    J Infect Dis. 2022 Feb 13. pii: 6527814. doi: 10.1093.
    >> Share

  240. BOSCH RJ, Gandhi RT, Mar H, Eron JJ, et al
    Associations between multiple measures of HIV-1 persistence on suppressive antiretroviral therapy.
    J Infect Dis. 2022 Feb 4. pii: 6522965. doi: 10.1093.
    >> Share

  241. MAHOMED S, Garrett N, Capparelli EV, Osman F, et al
    Safety and pharmacokinetics of monoclonal antibodies VRC07-523LS and PGT121 administered subcutaneously for HIV prevention.
    J Infect Dis. 2022 Feb 4. pii: 6522857. doi: 10.1093.
    >> Share

  242. SMITH RA, Wu VH, Song J, Raugi DN, et al
    Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations In HIV-2 Integrase: A Phenotypic Analysis Using An Expanded Panel of Site-Directed Mutants.
    J Infect Dis. 2022 Feb 3. pii: 6521074. doi: 10.1093.
    >> Share

  243. LAU JSY, Cromer D, Pinkevych M, Lewin SR, et al
    Balancing statistical power and risk in HIV cure clinical trial design.
    J Infect Dis. 2022 Feb 1. pii: 6519358. doi: 10.1093.
    >> Share

    January 2022
  244. LAURIE C, El-Zein M, Tota J, Khosrow-Khavar F, et al
    Efficacy of a carrageenan gel in increasing clearance of anal HPV infections in men: interim analysis of a double-blind randomized controlled trial.
    J Infect Dis. 2022 Jan 28. pii: 6516990. doi: 10.1093.
    >> Share

  245. GELPI M, Vestad B, Raju SC, Hansen SH, et al
    Association of the kynurenine pathway of tryptophan metabolism with HIV-related gut microbiota alterations and visceral adipose tissue accumulation.
    J Infect Dis. 2022 Jan 28. pii: 6516797. doi: 10.1093.
    >> Share

  246. ZURCHER K, Riou J, Morrow C, Ballif M, et al
    Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.
    J Infect Dis. 2022 Jan 18. pii: 6510424. doi: 10.1093.
    >> Share

  247. ZHANG Y, D'Souza G, Fakhry C, Bigelow EO, et al
    Oral HPV associated with differences in oral microbiota beta diversity and microbiota abundance.
    J Infect Dis. 2022 Jan 17. pii: 6509880. doi: 10.1093.
    >> Share

  248. KHALFI P, Suspene R, Caval V, Thiers V, et al
    APOBEC3C S188I polymorphism enhances context specific editing of Hepatitis B virus genome.
    J Infect Dis. 2022 Jan 12. pii: 6504007. doi: 10.1093.
    >> Share

  249. L'HONNEUR AS, Pipoli Da Fonseca J, Cokelaer T, Rozenberg F, et al
    JC Polyomavirus whole genome sequencing at the single molecule level reveals emerging neurotropic populations in Progressive Multifocal Leucoencephalopathy.
    J Infect Dis. 2022 Jan 3. pii: 6494525. doi: 10.1093.
    >> Share

    December 2021
  250. LUCIER A, Fong Y, Li SH, Dennis M, et al
    Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV.
    J Infect Dis. 2021 Dec 28. pii: 6486389. doi: 10.1093.
    >> Share

  251. WEITZMANN MN, Weiss D, Vikulina T, Roser-Page S, et al
    Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model.
    J Infect Dis. 2021 Dec 28. pii: 6485936. doi: 10.1093.
    >> Share

  252. VERBURGH ML, Boyd A, Wit FWNM, Schim van der Loeff MF, et al
    Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV.
    J Infect Dis. 2021 Dec 20. pii: 6470931. doi: 10.1093.
    >> Share

  253. SAHA A, Escudero J, Layouni T, Richardson B, et al
    Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum.
    J Infect Dis. 2021 Dec 20. pii: 6470923. doi: 10.1093.
    >> Share

  254. VILLALBA JA, Maus MV, Frigault MJ, Zaffini R, et al
    False-positive HIV testing in patients receiving lentivirus-based chimeric antigen receptor T-cell therapy: A case report, review of the literature and proposed recommendations.
    J Infect Dis. 2021 Dec 20. pii: 6470480. doi: 10.1093.
    >> Share

  255. SCHOEPF IC, Thorball CW, Ledergerber B, Kootstra NA, et al
    Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years.
    J Infect Dis. 2021 Dec 15. pii: 6463311. doi: 10.1093.
    >> Share

  256. POERIO N, Caccamo N, La Manna MP, Olimpieri T, et al
    Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages.
    J Infect Dis. 2021 Dec 15. pii: 6463308. doi: 10.1093.
    >> Share

  257. BROCKMAN MA, Mwimanzi F, Lapointe HR, Sang Y, et al
    Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults.
    J Infect Dis. 2021 Dec 9. pii: 6458430. doi: 10.1093.
    >> Share

  258. MASWIME S, Pule C, Mtshali Z, Chawana R, et al
    HIV, Placental Lesions, and Adverse Perinatal Outcomes.
    J Infect Dis. 2021;224.
    >> Share

  259. AUSTIN MN, Meyn LA, Avolia HA, Petrina MA, et al
    Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.
    J Infect Dis. 2021 Dec 4. pii: 6449486. doi: 10.1093.
    >> Share

  260. KATSUYA H, Cook LBM, Rowan AG, Melamed A, et al
    Erratum to: Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
    J Infect Dis. 2021 Dec 4. pii: 6449345. doi: 10.1093.
    >> Share

    November 2021
  261. BARES SH, Smeaton LM, Scott SE, Smith BA, et al
    The Association Between Weight Gain, Sex, and Immune Activation Following the Initiation of Antiretroviral Therapy.
    J Infect Dis. 2021;224:1765-1774.
    >> Share

  262. TAILOR J, Foldi J, Generoso M, McCarty B, et al
    Disease Progression in Children With Perinatal Human Immunodeficiency Virus Correlates With Increased PD-1+ CD8 T Cells That Coexpress Multiple Immune Checkpoints.
    J Infect Dis. 2021;224:1785-1795.
    >> Share

  263. RAFFENBERG M, Engel T, Schoepf IC, Kootstra NA, et al
    Impact of Delaying Antiretroviral Treatment During Primary Human Immunodeficiency Virus Infection on Telomere Length.
    J Infect Dis. 2021;224:1775-1784.
    >> Share

  264. FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
    COVID-19 Vaccination Rates in a Global HIV Cohort.
    J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
    >> Share

  265. BALAKRISHNA S, Wolfensberger A, Kachalov V, Roth JA, et al
    Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study.
    J Infect Dis. 2021 Nov 18. pii: 6430793. doi: 10.1093.
    >> Share

  266. DUARTE G, Muresan P, Ward S, Laimon L, et al
    Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV.
    J Infect Dis. 2021 Nov 16. pii: 6429421. doi: 10.1093.
    >> Share

  267. STOCKDALE AJ, Meiring JE, Shawa IT, Thindwa D, et al
    Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi.
    J Infect Dis. 2021 Nov 9. pii: 6424415. doi: 10.1093.
    >> Share

    October 2021
  268. STERN J, Solomon A, Dantanarayana A, Pascoe R, et al
    Cell-associated HIV RNA has a Circadian Cycle in Males Living with HIV on Antiretroviral Therapy.
    J Infect Dis. 2021 Oct 16. pii: 6398479. doi: 10.1093.
    >> Share

  269. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    >> Share

  270. SMITH JA, Garnett GP, Hallett TB
    The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study.
    J Infect Dis. 2021;224:1179-1186.
    >> Share

  271. ROTH JA, Radevski G, Marzolini C, Rauch A, et al
    Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.
    J Infect Dis. 2021;224:1198-1208.
    >> Share

  272. STONE M, Rosenbloom DIS, Bacchetti P, Deng X, et al
    Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
    J Infect Dis. 2021;224:1209-1218.
    >> Share

  273. VERBOEKET SO, Wit FW, Verheij E, van Zoest RA, et al
    Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex With Men Have Higher CD8+ T-Cell Counts and Lower CD4+/CD8+ T-Cell Ratios Compared With HIV-Negative Heterosexual Men.
    J Infect Dis. 2021;224:1187-1197.
    >> Share

  274. TINGGAARD M, Slotved HC, Fuursted K, Storgaard M, et al
    Oral and anal carriage of Streptococcus pneumoniae among sexually active men with HIV who have sex with men.
    J Infect Dis. 2021 Oct 8. pii: 6383604. doi: 10.1093.
    >> Share

  275. AKATA K, Leung JM, Yamasaki K, Filho FSL, et al
    Altered polarization and impaired phagocytic activity of lung macrophages in people with HIV and COPD.
    J Infect Dis. 2021 Oct 5. pii: 6381638. doi: 10.1093.
    >> Share

  276. LECUYER R, Issa N, Tessoulin B, Lavergne RA, et al
    Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia.
    J Infect Dis. 2021 Oct 4. pii: 6380657. doi: 10.1093.
    >> Share

    September 2021
  277. PELUSO MJ, Lu S, Tang AF, Durstenfeld MS, et al
    Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021 Sep 27. pii: 6376537. doi: 10.1093.
    >> Share

  278. GAY CL, James KS, Tuyishime M, Falcinelli SD, et al
    Stable Latent HIV Infection and Low-Level Viremia Despite Treatment with the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
    J Infect Dis. 2021 Sep 25. pii: 6375363. doi: 10.1093.
    >> Share

    May 2021
  279. SCHNITTMAN SR, Deitchman AN, Beck-Engeser G, Ahn H, et al
    Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus.
    J Infect Dis. 2021;223:1621-1630.
    >> Share

  280. MUKERJI SS, Misra V, Lorenz DR, Chettimada S, et al
    Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2021;223:1601-1611.
    >> Share

    April 2021
  281. ERLANDSON KM, Wilson MP, MaWhinney S, Rapaport E, et al
    The Impact of Moderate or High-Intensity Combined Exercise on Systemic Inflammation Among Older Persons With and Without HIV.
    J Infect Dis. 2021;223:1161-1170.
    >> Share

  282. VINHAES CL, Sheikh V, Oliveira-de-Souza D, Wang J, et al
    An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study.
    J Infect Dis. 2021;223:1275-1283.
    >> Share

    March 2021
  283. MAFFEI VJ, Siggins RW, Luo M, Brashear MM, et al
    Alcohol Use Is Associated With Intestinal Dysbiosis and Dysfunctional CD8+ T-Cell Phenotypes in Persons With Human Immunodeficiency Virus.
    J Infect Dis. 2021;223:1029-1039.
    >> Share

  284. CHAZOT R, Botelho-Nevers E, Mariat C, Fresard A, et al
    Cystatin C and Urine Albumin to Creatinine Ratio Predict 5-Year Mortality and Cardiovascular Events in People Living With HIV.
    J Infect Dis. 2021;223:885-892.
    >> Share

  285. ZHOU S, Sizemore S, Moeser M, Zimmerman S, et al
    Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.
    J Infect Dis. 2021;223:876-884.
    >> Share

  286. RICH SN, Poschman K, Hu H, Mavian C, et al
    Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis.
    J Infect Dis. 2021;223:866-875.
    >> Share

    February 2021
  287. RYOM L, Lundgren JD, Reiss P, Ross M, et al
    The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.
    J Infect Dis. 2021;223:632-637.
    >> Share

  288. AJAYKUMAR A, Zhu M, Kakkar F, Brophy J, et al
    Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    J Infect Dis. 2021;223:621-631.
    >> Share

  289. POPOVICH KJ
    Using Genomic Sequencing to Delineate Community Networks of Methicillin-Resistant Staphylococcus aureus Transmission Among Men Who Have Sex With Men.
    J Infect Dis. 2021;223:543-546.
    >> Share

  290. FRANCESCHINI E, De Biasi S, Digaetano M, Bianchini E, et al
    Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy.
    J Infect Dis. 2021;223:482-493.
    >> Share

  291. MAHOMED S, Garrett N, Baxter C, Abdool Karim Q, et al
    Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
    J Infect Dis. 2021;223:370-380.
    >> Share

  292. CYKTOR JC, Bosch RJ, Mar H, Macatangay BJ, et al
    Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
    J Infect Dis. 2021;223:462-470.
    >> Share

  293. SERRANO-VILLAR S, Sanchez-Carrillo S, Talavera-Rodriguez A, Lelouvier B, et al
    Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery.
    J Infect Dis. 2021;223:471-481.
    >> Share

    August 2020
  294. TESSEMA SK, Hathaway NJ, Teyssier NB, Murphy M, et al
    Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome.
    J Infect Dis. 2020 Aug 25. pii: 5897005. doi: 10.1093.
    >> Share

    July 2020
  295. CATLETT B, Bajis S, Starr M, Dore GJ, et al
    Evaluation of the Aptima HCV Quant Dx Assay for HCV RNA detection from finger-stick capillary dried blood spot and venepuncture-collected samples.
    J Infect Dis. 2020 Jul 25. pii: 5876378. doi: 10.1093.
    >> Share

  296. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Extent of in-utero transfer of tenofovir from mother to fetus: a paired analysis of hair specimens collected at birth from a cohort in the United States.
    J Infect Dis. 2020 Jul 4. pii: 5867166. doi: 10.1093.
    >> Share

    December 2019
  297. PHILLIPS A, Cambiano V, Johnson L, Nakagawa F, et al
    Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance.
    J Infect Dis. 2019 Dec 18. pii: 5680588. doi: 10.1093.
    >> Share

  298. WIJERS JNAP, Dukers-Muijrers NHTM, van Liere GAFS, Dirks JAMC, et al
    Men and women have an equal oropharyngeal and anorectal Chlamydia trachomatis bacterial load: a comparison of three anatomic sites.
    J Infect Dis. 2019 Dec 16. pii: 5678512. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016